1 results match your criteria: "Memory Resource and Research Centre of Paris-Broca-Ile de France[Affiliation]"
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
J Neurol Neurosurg Psychiatry
June 2023
Université Paris Cité, EA 4468, Hopital Broca, Geriatric department, Memory Resource and Research Centre of Paris-Broca-Ile de France, APHP, Paris, France.
Objectives: Plasma P-tau181 is an increasingly established diagnostic marker for Alzheimer's disease (AD). Further validation in prospective cohorts is still needed, as well as the study of confounding factors that could influence its blood level.
Methods: This study is ancillary to the prospective multicentre Biomarker of AmyLoid pepTide and AlZheimer's diseAse Risk cohort that enrolled participants with mild cognitive impairment (MCI) who were examined for conversion to dementia for up to 3 years.